AC
ORIC icon

AXQ Capital’s Oric Pharmaceuticals ORIC Stock Holding History

AXQ Capital’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$396K Buy
+36,519
New +$331K 0.04% 548
2026
Q1 		– Sell
-10,366
Closed -$84.8K – 1195
2025
Q4 		$84.8K Buy
+10,366
New +$119K 0.02% 671
2025
Q3 		– Sell
-12,950
Closed -$131K – 760
2025
Q2 		$131K Buy
12,950
+2,889
+29% +$19.4K 0.04% 498
2025
Q1 		$56.1K Buy
+10,061
New +$88K 0.02% 466

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AXQ Capital's ORIC Position: Q2 2026 in Review

AXQ Capital opened a new position in Oric Pharmaceuticals (ORIC) in Q2 2026: 36,519 shares worth $396K. The stake represents 0.04% of the portfolio and ranks #548 among its holdings. This is a return to the name: AXQ Capital previously reported a position in ORIC as recently as Q4 2025.

AXQ Capital first reported a position in ORIC in Q1 2025 and has held it in 4 quarters since. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • AXQ Capital held 36,519 shares of Oric Pharmaceuticals worth $396K as of Q2 2026.
  • Oric Pharmaceuticals was a new AXQ Capital position in Q2 2026.
  • Oric Pharmaceuticals made up 0.04% of AXQ Capital's portfolio in Q2 2026, its #548 holding.
  • AXQ Capital first reported a position in Oric Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.